Free radical formation by antitumor quinones
- 16 January 1989
- journal article
- review article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 6 (1) , 63-101
- https://doi.org/10.1016/0891-5849(89)90162-7
Abstract
No abstract availableKeywords
This publication has 298 references indexed in Scilit:
- A free radical scavenger role for daunomycin: Inhibition of nonenzymatic oxidation of NADHBiochemical and Biophysical Research Communications, 1987
- Mitomycin C analogs with increased metal complexing abilityJournal of Medicinal Chemistry, 1986
- Lapachol inhibition of DT-Diaphorase (NAD(P)H:Quinone Dehydrogenase)Biochemical and Biophysical Research Communications, 1986
- Mitoxantrone affects topoisomerase activities in human breast cancer cellsBiochemical and Biophysical Research Communications, 1986
- Degradation of DNA by metalloanthracyclines: Requirement for metal ionsBiochemical and Biophysical Research Communications, 1986
- Interactions of anticancer quinone drugs, aclacinomycin A, adriamycin, carbazilquinone, and mitomycin C, with NADPH-cytochrome P-450 reductase, xanthine oxidase and oxygen.Journal of Pharmacobio-Dynamics, 1986
- Diaziquone as a potential agent for photoirradiation therapy: Formation of the semiquinone and hydroxyl radicals by visible lightBiochemical and Biophysical Research Communications, 1985
- Adriamycin affects plasma membrane redox functionsBiochemical and Biophysical Research Communications, 1980
- The 1979 catalog of human genes and chromosome assignmentsCytogenetic and Genome Research, 1979
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977